Main articles (2023-2015)

Korvyakov SA., Alekhin AI., Moracheva NN., Lyubavskaya TYa., Seledtsov VI. Complex immunotherapy in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD). Patogenez [Pathogenesis]. 2023; 21(2): 62-69 (in Russian)

Seledtsov VI, Seledtsova GV, von Delwig AA. Immune-based, multifaceted inactivation of pathogenic T lymphocytes in treating autoimmune diseases. Explor Immunol. 2023;3:506–12. https://doi.org/10.37349/ei.2023.00117

Ivanova I.P., Seledtsova G.V., Seledtsov V.I., Khabalova T.S., Dorzhieva A.B. Experimental application results of mesenchymal stem cell microvesicles in the mouse model of acute renal failure. Medical Immunology (Russia). 2023;25(3):665-672. https://doi.org/10.15789/1563-0625- EAR-2716

Seledtsov VI, Dorzhieva AB, Seledetsova GV. Antitumor and immunomodulatory effects of oxygen therapy. Medical Immunology (Russia). 2023; 25(6): 1319-1338.

Seledtsov VI, Darinskas A, Von Delwig A, Seledtsova GV. Inflammation сontrol and immunotherapeutic strategies in comprehensive cancer treatment. Metabolites. 2023 Jan 13;13(1):123. doi: 10.3390/metabo13010123. PMID: 36677048; PMCID: PMC9865335.

Seledtsov VI, von Delwig A. Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer. Expert Opin Biol Ther. 2021 Mar;21(3):323-342. doi: 10.1080/14712598.2021.1828338. Epub 2020 Oct 3.

Seledtsov VI, Malashchenko VV, Meniailo ME, Atochin DN, Seledtsova GV, Schepetkin IA. Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T cells. Eur J Pharm. 2020; 2020 Jul 5; 878:173116. doi: 10.1016/j.ejphar

Seledtsov VI., von Delwig A.A. Immune memory limits human longevity: The role of memory СD4+ T cells in age-related immune abnormalities. Expert Rev Vac. 2020 Mar; 19(3):209-215. doi: 10.1080/14760584.2020.1745638..

Seledtsov VI, Malashchenko VV, Meniailo ME, Gazatova ND, Seledtsova GV. Granulocyte colony-stimulating factor downregulates interferon-gamma receptor expression and stimulates interleukin-6 production in activated human macrophages. Growth Factors. 2019 Aug; 37 (3-4):164-169. doi: 10.1080/08977194.2019.1662418.

Seledtsov VI., MalashchenkoV.V., Gazatova N.D., Meniailo ME., Morozova EM., Seledtsova GV. Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis. Human Vaccines & Immunotherapeutics. . 2019;15(12):2903-2909. doi: 10.1080/21645515.2019.1614396.

Seledtsov VI., Seledtsova GV. Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: Implications for immunotherapy of autoimmune and allergenic disorders. Exp Rev Clin Immunol. 2019 Jul;15(7):701-706. doi: 10.1080/1744666X.2019.1617698.

Melashchenko O.V., Meniailo M.E., Malashchenko V.V., Gazatova N.D., Goncharov N.D., Seledtsova G.V., Seledtsov V.I. Erythropoietin-mediated modulation of human macrophage functionality. Current Pharmaceutical Biotechnology. 2018;19(11):902-9.

Seledtsov VI, Seledtsova GV. Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article. Oncotarget. 2018; ;9(87):35790-4.

Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, Seledtsova GV, Seledtsov VI. Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophages. Int Immunopharmacol. 2018; 56:217-21.

Malashchenko VV, Meniailo ME, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, Seledtsova G,V Seledtsov VI. Direct anti-inflammatory effects of granulocyte colony-stimulating factor (G-CSF) on activation and functional properties of human T cell subpopulations in vitro. Cell Immunol. 2018; 325:23-32.

Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, Seledtsova G,V Seledtsov VI. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017; 50:178-85.

Seledtsov V.I., Seledtsova G.V. A possible role for idiotype/ anti-idiotype B–T cell interactions in maintaining immune memory. Front Immunol. 2017; 8:409. doi: 10.3389/fimmu.

Shmarov VA, Malashchenko VV, Meniailo ME, Gazatova ND, Todosenko NM, Melashchenko OB, Goncharov AG, Seledtsov VI. Direct effects of interleukin-7 on the functionality of human T cells in vitro. Eur Cytokine Netw. 2017; 27(4):102-7. doi: 10.1684/ecn.2016.0385.

Seledtsov V.I., Darinskas A., Seledtsova G.V. Xenogenic normal tissue-derived vaccines for breaking the immune tolerance to tumor-associated, antigens. Patent WO 2016046651 A1, 2016.

Seledtsova G.V.1, Irina P. Ivanova I.P., Shishkov А.А., Seledtsov V.I. Immune responses to polyclonal T-cell vaccination in patients with progressive multiple sclerosis. J Immunotox. 2016; 13(6):879-84.

Seledtsova G.V., Shishkov A.A., Kaschenko E.A, Seledtsov V.I. Xenonogeneic cell-based vaccine therapy for colorectal cancer: association of clinical effects with vaccine-induced immune responses. Biomed Pharmacother. 2016; 83: 1247-52.

Seledtsova G.V., Shishkov A.A., Kaschenko E. A.,. Goncharov A. G., Gazatova N. D., Seledtsov V.I. Xenonogeneic cell-based vaccine therapy for stage III melanoma: safety, immune-mediated responses and survival benefits. Eur J Dermat. 2016; 26: 138-43.

Todosenko NM, Shmarov VA, Malashchenko VV, Meniailo ME, Melashchenko OB, Gazatova ND, Goncharov AG, Seledtsov VI. Erythropoietin exerts direct immunomodulatory effects on the cytokine production by activated human T-lymphocytes. Int Immunopharmacol. 2016 ; 36: 277-81.

Atochin D.N., Schepetkin I.A., Khlebnikov A.I., Seledtsov V.I., Swanson H., Quinn M.T., Huang P.L. A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia–reperfusion injury in mice. Neurosci Lett. 2016; 618:45-9.

Seledtsov V.I., Goncharov A.G., Seledtsova G.V. Multiple-purpose immunotherapy for cancer. Biomedicine & Pharmacotherapy. 2015; 76: 24–9.

Seledtsov V.I., Goncharov A.G., Seledtsova G.V. Clinically feasible approaches to potentiating cancer cell-based immunotherapies. Human Vaccines & Immunotherapeutics.2015; 11(4):851-69.

Ivanova I.P, Seledtsova G.V., Mamaev S.V., Shishkov А.А., Seledtsov V.I. Immune responses induced by T-cell vaccination in patients with rheumatoid arthritis. Human Vaccines & Immunotherapeutics. 2014; 10(5):1221-7. doi: 10.4161/hv.28299.